Sabra Health Care REIT Insider Sale: 750 Shares Reported on Form 4

Rhea-AI Filing Summary

Insider sale recorded by Michael J. Foster at Sabra Health Care REIT (SBRA). On 08/19/2025 the filing reports a disposition of 750 shares of the issuer's common stock under transaction code G, with $0 price reported for that line. After the reported transaction, the reporting person is shown as beneficially owning 72,317 shares directly and 42,411.745 shares indirectly through a 401(k) plan. The filing notes that the total direct holdings include 6,815 unvested stock units and 44,982 vested stock units with deferred payment; each stock unit equals one share. The form is signed by Michael Costa as attorney-in-fact on 08/19/2025.

Positive

• Form discloses both direct (72,317) and indirect (42,411.745) beneficial ownership, providing transparency
• Notes clearly state composition of direct holdings: 6,815 unvested units and 44,982 vested but deferred units

Negative

• None.

Insights

Financial Analyst

TL;DR: A small, routine insider disposition leaves substantial remaining insider holdings; transaction appears immaterial to company capital structure.

The Form 4 shows a reported sale of 750 shares (code G) completed on 08/19/2025, after which the reporting person holds 72,317 shares directly and 42,411.745 indirectly via a 401(k). The footnote clarifies composition of direct holdings including 6,815 unvested units and 44,982 vested but deferred units. Given the scale of remaining holdings, this single disposition is small in absolute terms and does not change the insider's overall stake materially.

Corporate Governance Expert

TL;DR: Disclosure appears complete for the reported transaction; documentation includes deferred and unvested unit detail and an attorney-in-fact signature.

The filing provides the necessary breakdown of beneficial ownership between direct and indirect holdings and discloses the nature of stock units (vested, deferred, unvested). The signature block shows filing by an attorney-in-fact, which is permitted when properly authorized. There is no indication in the document of any material governance event or change in control.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOSTER MICHAEL J

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CA 92782

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		G		750	D	$0	72,317(1)	D
Common Stock								42,411.745	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 6,815 unvested stock units and 44,982 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction was reported on the Form 4 for SBRA?

The filing reports a disposition of 750 shares of Sabra Health Care REIT common stock on 08/19/2025 (transaction code G).

How many shares does the reporting person own after the transaction?

After the reported transaction, the reporting person beneficially owns 72,317 shares directly and 42,411.745 shares indirectly via a 401(k) plan.

What do the stock unit footnotes reveal in the Form 4?

The footnote states the direct holdings include 6,815 unvested stock units and 44,982 stock units that have vested but payment has been deferred, with each unit representing one share.

Who signed the Form 4 and when?

The form is signed by Michael Costa, as Attorney-in-Fact on 08/19/2025.